Login to Your Account


Biotech companies in funding overdrive during second quarter

By Peter Winter

Monday, July 7, 2014

Despite the fact that biotech share values were heading south at the beginning of the second quarter of 2014, the short-lived negative environment failed to scare off investors completely, with companies maintaining the momentum built from the first quarter, as far as raising cash is concerned.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription